Can MGMT promoter methylation status be used as a prognostic and predictive marker for glioblastoma multiforme at the present time?: A word of caution

Saved in:
Bibliographic Details
Published in:Strahlentherapie und Onkologie 2013-12, Vol.189 (12), p.993-995
Main Authors: Fietkau, R., Putz, F., Lahmer, G., Semrau, S., Buslei, R.
Format: Article
Language:English
Subjects:
Biomarkers, Tumor - genetics
Brain Neoplasms - diagnosis
Brain Neoplasms - genetics
CpG Islands - genetics
DNA Methylation - genetics
DNA Modification Methylases - genetics
DNA Repair Enzymes - genetics
DNA, Neoplasm - genetics
Editorial
Genetic Markers - genetics
Genetic Predisposition to Disease - genetics
Glioblastoma - diagnosis
Glioblastoma - genetics
Humans
Medicine
Medicine & Public Health
Oncology
Prognosis
Radiotherapy
Tumor Suppressor Proteins - genetics
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0179-7158
1439-099X
DOI:10.1007/s00066-013-0459-2